Adult Solid Tumor

Oncology
2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

AstraZeneca
AstraZenecaCAMBRIDGE, United Kingdom
1 program
1
AZD3965Phase 11 trial
Active Trials
NCT01791595Completed53Est. Nov 2020
Debiopharm
DebiopharmSwitzerland - Lausanne
1 program
1
RP-6306Phase 11 trial
Active Trials
NCT05147272TerminatedEst. Aug 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
DebiopharmRP-6306
AstraZenecaAZD3965

Clinical Trials (2)

Total enrollment: 53 patients across 2 trials

Study of RP-6306 With Gemcitabine in Advanced Solid Tumors

Start: Dec 2021Est. completion: Aug 2024
Phase 1Terminated

A Phase I Trial of AZD3965 in Patients With Advanced Cancer

Start: Apr 2013Est. completion: Nov 202053 patients
Phase 1Completed

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space